Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Biomedical Research|November 8, 2017
Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteinsVassilis I Zannis, Shi Su, Panagiotis FotakisBiochemistry|May 8, 2015
The Effect of Natural LCAT Mutations on the Biogenesis of HDLPanagiotis Fotakis, Jan Albert Kuivenhoven, Eugene Dafnis, et al.Metabolism: Clinical and Experimental|June 22, 2018
HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathwayDimitris Theofilatos, Panagiotis Fotakis, Efi Valanti, et al.Journal of Lipid Research|April 30, 2014
apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDLPanagiotis Fotakis, Alexander Vezeridis, Ioannis Dafnis, et al.Lipids|November 3, 2017
Tissue Uptake Mechanisms Involved in the Clearance of Non-Protein Nanoparticles that Mimic LDL Composition: A Study with Knockout and Transgenic MiceElaine N Daminelli, Panagiotis Fotakis, Carlos H Mesquita, et al.Handbook of Experimental Pharmacology|December 20, 2014
HDL biogenesis, remodeling, and catabolismVassilis I Zannis, Panagiotis Fotakis, Georgios Koukos, et al.Atherosclerosis|September 13, 2015
Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in miceIoanna Tiniakou, Zoi Kanaki, Spiros Georgopoulos, et al.Journal of Lipid Research|October 15, 2013
Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDLPanagiotis Fotakis, Ioanna Tiniakou, Andreas K Kateifides, et al.Journal of Lipid Research|November 8, 2012
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCATAdelina Duka, Panagiotis Fotakis, Dimitra Georgiadou, et al.Metabolism: Clinical and Experimental|December 7, 2021
Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPKEftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Panagiotis Fotakis, et al.Pageof 2